Published Date：Mar.2021
Industry：Chemical & Material
Pages：120 Table Number：145
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Drugs for Respiratory Syncytial Virus (RSV) market in this environment. In terms of revenue, this research report indicated that the global Drugs for Respiratory Syncytial Virus (RSV) market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Drugs for Respiratory Syncytial Virus (RSV) industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Bavarian Nordic aims at producing XX K Units Drugs for Respiratory Syncytial Virus (RSV) in 2020, with XX % production to take place in global market, Crucell accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Drugs for Respiratory Syncytial Virus (RSV) Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Drugs for Respiratory Syncytial Virus (RSV) Market? Bavarian Nordic Crucell GlaxoSmithKline Humabs BioMed Astellas Pharma Artificial Cell Technologies Ablynx AmVac Roche Celltrion AlphaVax Novavax ADMA Biologics GenVec Codagenix Aridis Pharmaceuticals Agilvax Biota Pharmaceuticals CureVac Gilead Sciences AstraZeneca Emergent ... Major Type of Drugs for Respiratory Syncytial Virus (RSV) Covered in XYZResearch report: Ribavirin Bronchodilator Application Segments Covered in XYZResearch Market Infants (Under 6 Month Old) Babies and Children Adults Old For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Drugs for Respiratory Syncytial Virus (RSV) Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Ribavirin -Product Introduction and Major Manufacturers 1.1.2 Bronchodilator -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Drugs for Respiratory Syncytial Virus (RSV) Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Drugs for Respiratory Syncytial Virus (RSV) Market 3.1.1 Top Companies leading Drugs for Respiratory Syncytial Virus (RSV) Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Drugs for Respiratory Syncytial Virus (RSV) Market 3.2.1 Top Companies leading Drugs for Respiratory Syncytial Virus (RSV) Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Drugs for Respiratory Syncytial Virus (RSV) Market 3.3.1 Top Companies leading Drugs for Respiratory Syncytial Virus (RSV) Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Drugs for Respiratory Syncytial Virus (RSV) Market 3.4.1 Top Companies leading Drugs for Respiratory Syncytial Virus (RSV) Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Drugs for Respiratory Syncytial Virus (RSV) Market 3.5.1 Top Companies leading Drugs for Respiratory Syncytial Virus (RSV) Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Market 3.6.1 Top Companies leading Drugs for Respiratory Syncytial Virus (RSV) Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Drugs for Respiratory Syncytial Virus (RSV) Market 3.7.1 Top Companies leading Drugs for Respiratory Syncytial Virus (RSV) Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Drugs for Respiratory Syncytial Virus (RSV) Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Drugs for Respiratory Syncytial Virus (RSV) Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2021-2027) 5.2 Global Drugs for Respiratory Syncytial Virus (RSV) Sales Value and Growth Rate (2021-2027) 6 Drugs for Respiratory Syncytial Virus (RSV) Competitive Analysis 6.1 Bavarian Nordic 6.1.1 Bavarian Nordic Company Profiles 6.1.2 Bavarian Nordic Product Introduction 6.1.3 Bavarian Nordic Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Crucell 6.2.1 Crucell Company Profiles 6.2.2 Crucell Product Introduction 6.2.3 Crucell Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 GlaxoSmithKline 6.3.1 GlaxoSmithKline Company Profiles 6.3.2 GlaxoSmithKline Product Introduction 6.3.3 GlaxoSmithKline Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Humabs BioMed 6.4.1 Humabs BioMed Company Profiles 6.4.2 Humabs BioMed Product Introduction 6.4.3 Humabs BioMed Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Astellas Pharma 6.5.1 Astellas Pharma Company Profiles 6.5.2 Astellas Pharma Product Introduction 6.5.3 Astellas Pharma Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Artificial Cell Technologies 6.6.1 Artificial Cell Technologies Company Profiles 6.6.2 Artificial Cell Technologies Product Introduction 6.6.3 Artificial Cell Technologies Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 Ablynx 6.7.1 Ablynx Company Profiles 6.7.2 Ablynx Product Introduction 6.7.3 Ablynx Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 AmVac 6.8.1 AmVac Company Profiles 6.8.2 AmVac Product Introduction 6.8.3 AmVac Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 6.9 Roche 6.9.1 Roche Company Profiles 6.9.2 Roche Product Introduction 6.9.3 Roche Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue (2016-2021) 6.9.4 SWOT Analysis 6.10 Celltrion 6.10.1 Celltrion Company Profiles 6.10.2 Celltrion Product Introduction 6.10.3 Celltrion Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue (2016-2021) 6.10.4 SWOT Analysis 6.11 AlphaVax 6.12 Novavax 6.13 ADMA Biologics 6.14 GenVec 6.15 Codagenix 6.16 Aridis Pharmaceuticals 6.17 Agilvax 6.18 Biota Pharmaceuticals 6.19 CureVac 6.20 Gilead Sciences 6.21 AstraZeneca 6.22 Emergent 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Drugs for Respiratory Syncytial Virus (RSV) Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales (K Unit) by Type (2026-2027) Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales (K Unit) and Growth Rate (2026-2027) Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share (%) by Type (2019 -2020) Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) by Type (2026-2027) Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales Value Market Share (%) by Type (2019-2020) Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales (K Unit) by Application (2026-2027) Table China Drugs for Respiratory Syncytial Virus (RSV) Sales (K Unit) of Major Company (2016-2021) Table China Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share of Major Company (2016-2021) Table China Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) of Major Company (2016-2021) Figure China Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) and Growth Rate (2016-2021) Table China Drugs for Respiratory Syncytial Virus (RSV) Sales Value Share of Major Company (2016-2021) Table China Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) Table China Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Figure China Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Table EU Drugs for Respiratory Syncytial Virus (RSV) Sales (K Unit) of Major Company (2016-2021) Table EU Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share of Major Company (2016-2021) Table EU Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) of Major Company (2016-2021) Figure EU Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Drugs for Respiratory Syncytial Virus (RSV) Sales Value Share of Major Company (2016-2021) Table EU Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) Table EU Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Figure EU Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales (K Unit) of Major Company (2016-2021) Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share of Major Company (2016-2021) Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) of Major Company (2016-2021) Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Value Share of Major Company (2016-2021) Table USA Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Table Japan Drugs for Respiratory Syncytial Virus (RSV) Sales (K Unit) of Major Company (2016-2021) Table Japan Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share of Major Company (2016-2021) Table Japan Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Drugs for Respiratory Syncytial Virus (RSV) Sales Value Share of Major Company (2016-2021) Table Japan Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) Table Japan Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Figure Japan Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Table India Drugs for Respiratory Syncytial Virus (RSV) Sales (K Unit) of Major Company (2016-2021) Table India Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share of Major Company (2016-2021) Table India Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) of Major Company (2016-2021) Figure India Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) and Growth Rate (2016-2021) Table India Drugs for Respiratory Syncytial Virus (RSV) Sales Value Share of Major Company (2016-2021) Table India Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) Table India Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Figure India Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Table Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share of Major Company (2016-2021) Table Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales Value Share of Major Company (2016-2021) Table Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Figure Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Table South America Drugs for Respiratory Syncytial Virus (RSV) Sales (K Unit) of Major Company (2016-2021) Table South America Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share of Major Company (2016-2021) Table South America Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) of Major Company (2016-2021) Figure South America Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Drugs for Respiratory Syncytial Virus (RSV) Sales Value Share of Major Company (2016-2021) Table South America Drugs for Respiratory Syncytial Virus (RSV) Price (USD/Unit), by Type (2019-2020) Table South America Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Figure South America Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Drugs for Respiratory Syncytial Virus (RSV) Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Drugs for Respiratory Syncytial Virus (RSV) Figure Cost Structure of Drugs for Respiratory Syncytial Virus (RSV) in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Bavarian Nordic Profiles Table Bavarian Nordic Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Bavarian Nordic Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Bavarian Nordic SWOT Analysis Table Crucell Profiles Table Crucell Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Crucell Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Crucell SWOT Analysis Table GlaxoSmithKline Profiles Table GlaxoSmithKline Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table GlaxoSmithKline Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure GlaxoSmithKline SWOT Analysis Table Humabs BioMed Profiles Table Humabs BioMed Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Humabs BioMed Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Humabs BioMed SWOT Analysis Table Astellas Pharma Profiles Table Astellas Pharma Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Astellas Pharma Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Astellas Pharma SWOT Analysis Table Artificial Cell Technologies Profiles Table Artificial Cell Technologies Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Artificial Cell Technologies Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Artificial Cell Technologies SWOT Analysis Table Ablynx Profiles Table Ablynx Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Ablynx Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Ablynx SWOT Analysis Table AmVac Profiles Table AmVac Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table AmVac Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure AmVac SWOT Analysis Table Roche Profiles Table Roche Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Roche Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Roche SWOT Analysis Table Celltrion Profiles Table Celltrion Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Celltrion Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Celltrion SWOT Analysis Table AlphaVax Profiles Table AlphaVax Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table AlphaVax Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure AlphaVax SWOT Analysis Table Novavax Profiles Table Novavax Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Novavax Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Novavax SWOT Analysis Table ADMA Biologics Profiles Table ADMA Biologics Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table ADMA Biologics Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure ADMA Biologics SWOT Analysis Table GenVec Profiles Table GenVec Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table GenVec Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure GenVec SWOT Analysis Table Codagenix Profiles Table Codagenix Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Codagenix Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Codagenix SWOT Analysis Table Aridis Pharmaceuticals Profiles Table Aridis Pharmaceuticals Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Aridis Pharmaceuticals Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Aridis Pharmaceuticals SWOT Analysis Table Agilvax Profiles Table Agilvax Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Agilvax Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Agilvax SWOT Analysis Table Biota Pharmaceuticals Profiles Table Biota Pharmaceuticals Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Biota Pharmaceuticals Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Biota Pharmaceuticals SWOT Analysis Table CureVac Profiles Table CureVac Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table CureVac Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure CureVac SWOT Analysis Table Gilead Sciences Profiles Table Gilead Sciences Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table Gilead Sciences Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Gilead Sciences SWOT Analysis Table AstraZeneca Profiles Table AstraZeneca Drugs for Respiratory Syncytial Virus (RSV) Product Introduction Table AstraZeneca Drugs for Respiratory Syncytial Virus (RSV) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure AstraZeneca SWOT Analysis
